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Background: Approximately 30 000 people undergo major emergency abdominal gastrointestinal
surgery annually, and 36 per cent of these procedures (around 10800) are carried out for emergency
colorectal pathology. Some 14 per cent of all patients requiring emergency surgery have a laparoscopic
procedure. The aims of the LaCeS (laparoscopic versus open colorectal surgery in the acute setting) fea-
sibility trial were to assess the feasibility, safety and acceptability of performing a large-scale definitive
phase III RCT, with a comparison of emergency laparoscopic versus open surgery for acute colorectal
pathology.
Methods: LaCeS was designed as a prospective, multicentre, single-blind, parallel-group, pragmatic
feasibility RCT with an integrated qualitative study. Randomization was undertaken centrally, with
patients randomized on a 1 : 1 basis between laparoscopic or open surgery.
Results: A total of 64 patients were recruited across five centres. The overall mean steady-state
recruitment rate was 1⋅2 patients per month per site. Baseline compliance for clinical and health-related
quality-of-life data was 99⋅8 and 93⋅8 per cent respectively. The conversion rate from laparoscopic to open
surgery was 39 (95 per cent c.i. 23 to 58) per cent. The 30-day postoperative complication rate was 27 (13
to 46) per cent in the laparoscopic arm and 42 (25 to 61) per cent in the open arm.
Conclusion: Laparoscopic emergency colorectal surgery may have an acceptable safety profile. Registra-
tion number: ISRCTN15681041 (http://www.controlled-trials.com).
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Background
TheUKNational Emergency LaparotomyAudit (NELA)1
has reported that approximately 30 000 people per annum
undergo major abdominal gastrointestinal surgery, and
that 36 per cent of these operations (around 10 800)
are carried out for emergency colorectal pathology. The
management of emergency colorectal pathology can be
challenging owing to the range of presenting pathology,
including colorectal cancer, inflammatory bowel disease
and diverticular disease, combined with variable patient
physiology, associated sepsis and potentially advanced dis-
ease. Emergency colorectal surgery is associated with sig-
nificant morbidity, with reported rates of postoperative
morbidity and mortality of 33–71 and 14–17 per cent
respectively2,3.
A number of initiatives have been launched to improve
outcomes in patients undergoing emergency laparotomy,
including the use of perioperative bundles to identify
high-risk patients4,5, timely management of sepsis and
delivery of consultant-led services. Surgeons have explored
the possibility of adopting a laparoscopic approach in
the emergency setting6–9. The current evidence base
informing the use of laparoscopic surgical resection in the
emergency colorectal setting is weak, being limited to a
small number of population-based registries and retro-
spective cohort studies10–12. However, there are a number
of emerging trials13–15 successfully investigating the role
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of laparoscopic lavage for perforated diverticulitis. Initial
reports for colorectal resection in the emergency setting
indicate benefits of laparoscopic surgery, but the findings
have not been uniform across a highly selected patient
population consisting of younger and physiologically fitter
patients10. There is a lack of transparent outcome report-
ing, with missing data on complications, reoperation rates
and mortality. In a systematic review of 39 studies, Agresta
and colleagues12 concluded that the current evidence for
emergency laparoscopic colorectal surgery was ‘early, con-
troversial and focused on short term outcomes’. The lack
of confirmatory data regarding the benefits of emergency
laparoscopic colorectal surgery has in part led to the lack of
adoption in clinical practice, with NELA1 reporting static
rates of emergency laparoscopic surgery of approximately
14 per cent over the past 3 years.
Surgical trials are associated with a number of practi-
cal and methodological challenges, which include difficul-
ties in randomization, lack of equipoise16, and variability
in experience and delivery of surgical interventions. Surgi-
cal trials in the emergency setting add an additional layer
of complexity given the time constraints associated with
delivering definitive treatment, and balancing these against
trial-related processes including consent and recruitment.
A number of surgical trials have closed early in the emer-
gency colorectal setting either because of poor recruit-
ment rates17,18 or a higher rate of adverse events than
anticipated13. Given these recognized difficulties, a feasi-
bility trial investigating emergency laparoscopic colorectal
surgery was designed. The LaCeS feasibility trial aimed to
assess the safety and acceptability of performing a phase III
RCT comparing laparoscopic with open surgery for emer-
gency colorectal pathology.
Methods
LaCeS was designed as a prospective, multicentre,
single-blind, parallel-group, pragmatic feasibility RCT
with an integrated qualitative study. The LaCeS feasibil-
ity trial protocol has been published previously19. The
LaCeS feasibility trial was approved by Yorkshire and the
Humber Research Ethics Committee (REC reference:
15/YH/0542).
Patients were recruited from five National Health Ser-
vice (NHS)Trusts across theUK. All participating sites had
dedicated emergency surgery services, with appropriate
provisions and expertise to conduct laparoscopic surgery.
Randomization was performed centrally, with patients ran-
domized on a 1 : 1 basis between laparoscopic or open
surgery using minimization incorporating a random ele-
ment, stratified by intended consultant surgeon, patient
age, BMI, ASAfitness grade, nature of the underlying
pathology and intended surgical procedure. Patients were
blinded to the treatment allocation for up to 7 days after
surgery, or until the day of discharge if earlier.
Eligibility
Patient inclusion criteria were: age at least 18 years; acute
colorectal pathology requiring resectional surgery; a
National Confidential Enquiry into Patient Outcome and
Death classification20 of urgent, requiring surgery within
between 2 and 6 h (classification 2A) or 6–18 h (classi-
fication 2B); suitability for both laparoscopic and open
surgery; and ability to either provide written informed
consent, or use of a personal consultee to provide advice
on participation in the event of temporary impairment in
capacity. Exclusion criteria were: haemodynamic instability
requiring inotropic support; acute non-colorectal pathol-
ogy; hand-assisted laparoscopic surgery; laparoscopy and
peritoneal lavage alone for colorectal pathology; insertion
of an endoscopic stent as a bridge to surgery; pregnancy;
pre-existing cognitive impairment; and participation in
another surgical trial. Surgeon eligibility criteria included:
a minimum of 50 previously performed laparoscopic colo-
rectal resections, with an annual rate of at least 20 elective
laparoscopic resections, and with equivalent experience in
the open setting.
Treatment
Patients received perioperative treatment according to the
institutional protocol. Laparoscopic surgery included the
use ofmultiport and single-port incisions to establish pneu-
moperitoneum and facilitate surgical resection. Conver-
sion to open surgery was defined as the use of a midline
laparotomy wound for any part of the colorectal dissection.
The use of a midline wound to facilitate specimen extrac-
tion was permissible. Open surgery was performed through
a standard midline laparotomy.
Outcome assessment
Amixed-methods approach was employed to assess recruit-
ment, feasibility and acceptability of the trial, and also the
safety profile of laparoscopic surgery in the acute setting.
Recruitment
The primary outcome measure of the LaCeS trial was the
overall recruitment rate, with an anticipated recruitment
rate of one patient per centre per month. Total numbers of
screened, eligible and randomized patients were examined
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to identify the total available population pool for inclusion
in a future phase III trial. Qualitative data were gathered to
assess both the practicalities of recruitment and random-
ization in the emergency setting.
Feasibility and acceptability of trial processes
The feasibility of data collection was examined, including
the collection of data on patient and disease characteris-
tics, operative factors, pain, health-related quality of life
(HRQoL), healthcare resource use, postoperative mor-
bidity and mortality, reoperation and readmission data.
Patient-reported generic HRQoL was measured using
the Short Form 12 (SF-12®; Optum, Eden Prairie,
Minnesota, USA)21 and EuroQol Five Dimensions
5L (EQ-5D-5L™; EuroQol Group, Rotterdam, the
Netherlands)22 questionnaires, whereas disease-specific
HRQoL was assessed using the Gastrointestinal Quality of
Life Index23. Patient-reported pain was measured using an
adapted version of the Brief Pain Inventory24. Healthcare
resource use was recorded using clinician-completed pro-
cedure and discharge forms, which documented procedure
staffing, assessments conducted, imaging, medications
and duration of hospital stay. Patient-completed forms
captured use of primary and secondary care. Data were
collected on paper by clinicians, trainees and research
nurses, and uploaded centrally to the clinical trials research
unit (CTRU).
The feasibility of longitudinal clinical and
patient-reported data collection was assessed at baseline,
3, 7 and 30 days, and 3, 6 and 12months (the latter using
a subset of patients) after surgery. Patient questionnaires
were completed in hospital; baseline questionnaires were
completed before randomization. Data compliance was
calculated for each of these time points as the proportion
of completed case report forms or HRQoL questionnaires
returned to the CTRU.
The Bang Blinding Index25 was used to assess the success
of blinding, on a scale ranging from –1 to 1; 1 indicates
a complete lack of blinding, 0 is consistent with perfect
blinding, and –1 indicates opposite guessing which may be
related to unblinding.
The acceptability of trial processes and follow-up were
assessed using in-depth qualitative interviews with clini-
cians and patients19. All interviews were informed by a
topic guide, and were audio recorded and transcribed ver-
batim. Qualitative data were analysed using the princi-
ples of thematic analysis26 in Nvivo27. Data were coded
independently by two qualitative researchers for emerg-
ing themes. Codes and themes were compared and con-
trasted between the two researchers, and any discrepancies
resolved by consensus.
Safety
The safety of laparoscopic emergency colorectal surgery
was assessed bymeasuring intraoperative and postoperative
complication and mortality rates. Patient safety indicators
(PSIs), as defined by the Agency for Healthcare Research
and Quality, were also collected. PSIs are a measure of
adverse events that patients experience as a result of expo-
sure to the healthcare system. Intraoperative conversion
rates were also calculated.
Endpoint evaluation
Endpoint evaluation was carried out to establish optimal
outcomemeasures and their timings to inform the design of
a large-scale definitive trial. Qualitative interviews explored
a range of clinical and patient-reported outcomes to iden-
tify which endpoint will have most meaning and value to
clinicians and patients as a primary endpoint for a defini-
tive trial. Candidate endpoints were analysed quantitatively
for completion rates and estimation of variability to help
inform future power calculations.
Sample size
The target sample size of at least 66 participants was
determined to allow precise estimation of parameters of
interest according to published recommendations28 and
accounting for a 10 per cent attrition rate. In addition, this
sample size allowed estimation of morbidity and mortality
rates in the laparoscopic arm, with 95 per cent two-sided
confidence intervals of at most ±17 per cent, allowing
the safety profile of laparoscopic emergency surgery to be
demonstrated. Achieving this recruitment target from five
centres over 15months also allowed pragmatic estimation
of the recruitment rate for a definitive phase III trial.
Statistical analysis
No endpoints were subjected to formal statistical testing as
no statistical hypotheses were proposed or powered. Data
were summarized descriptively using appropriate frequen-
cies and summary statistics, estimating levels of variabil-
ity using SAS® version 9.4 (SAS Institute, Cary, North
Carolina, USA). Data summaries included all randomized
patients according to the intervention received.
Results
Patients were recruited from two teaching hospitals and
three district general hospitals across the UK; four sites
provide emergency general surgery services and one site a
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Fig 1 CONSORT diagram for the trial
Total no. of patients undergoing emergency
colorectal resection recorded in NELA
database
n=564
Screened
n=119
Eligible
n=94
Ineligible n=25
 Diagnosis of acute non-colorectal pathology n=9
 Not suitable for laparoscopic and open surgery in opinion of operating surgeon n=5
 Not NCEPOD urgent classification n=3
 Not a suitable candidate for surgery in opinion of operating surgeon n=2
 Pre-existing cognitive impairment n=2
 Aged <18 years n=1
 Hand-assisted laparoscopic surgery n=1
 Emergency surgery for complication of elective surgery n=1
 No radiological imaging available before surgery n=1
Randomized
n=64
Laparoscopic surgery
n=33
Open surgery
n=31
Excluded n=30
 Patient approached but declined n=8
 Did not want to participate in a clinical trial n=1
 Did not want to be randomized n=1
 Did not want open surgery n=5
 Did not want to be blinded n=1
 Felt too ill to consent n=1
 Patient not approached n=22
 No randomizing consultant on call n=9
 Time constraints n=2
 Already consented for laparoscopic surgery n=3
 Patient stented n=1
 Previously offered laparoscopic surgery for flare-up of the condition n=1
 Consultant informed patient of type of surgery n=1
 Surgeon not happy to randomize patient n=1
 Consultant deemed patient too ill n=2
 Research team not made aware of patient n=1
 Patient did not speak English n=1
Lost to follow-up
 Withdrawal n=4
 Death n=1
Lost to follow-up
 Withdrawal n=1
 Death n=3
NELA, National Emergency Laparotomy Audit; NCEPOD, National Confidential Enquiry into Patient Outcome and Death.
dedicated colorectal emergency surgery service. Thirteen
surgeons recruited patients across all sites between July
2016 and November 2017. According to the NELA data
set, 564 patients were identified as undergoing emergency
colorectal resection across the five trial sites during the
recruitment period. A total of 119 patients were screened
and assessed for eligibility, of whom 94 (79⋅0 per cent)
were considered eligible and 72 (77 per cent of those
considered eligible) were approached to participate in the
trial. A total of 64 patients were randomized (53⋅8 per
cent of 119 screened; 89 per cent of 72 approached): 33
to laparoscopic and 31 to open surgery (Fig. 1). All patients
received the allocated treatment. Twenty-five patients were
not eligible for inclusion in the trial and eight patients
declined to participate. Twenty-two screened patients were
not approached by the research teams; the most common
reason for this was the lack of a randomizing consultant
on call.
The overall mean steady-state recruitment rate was 1⋅2
patients per month per site. The steady-state recruitment
rate per site varied between 0⋅57 and 2⋅78 patients per
month (Fig. 2). The overall mean steady-state recruitment
rate was 0⋅9 patients per month per site when the lead site
assumed the rate of the next highest recruiting site.
Baseline characteristics of all randomized patients are
shown in Table 1. The recruited patient population demon-
strated good representation of ages, physiological status
and disease types.
Qualitative interviews were conducted with 16 trial
patients (laparoscopic surgery, 6; laparoscopic procedure
converted to open surgery, 3; open surgery, 7) and 14
healthcare professionals (8 consultant surgeons, 3 research
nurses and 3 surgical trainees). Qualitative data indicated
that the recruitment and randomization processes were
acceptable. Patients were accepting of the trial design
and treatment arms, and were willing to be recruited and
randomized appropriately. A small proportion of patients
expressed a treatment preference, but this was not consid-
ered to be a barrier to participating in the trial. Barriers
to recruitment from a clinical perspective included: lack of
complete equipoise, this being most relevant in younger
patients and patients with inflammatory bowel disease;
difficulty in addressing and challenging patient treatment
preferences; and reluctance to approach acutely unwell
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Fig 2 Overall and monthly recruitment to LaCeS feasibility trial
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patients or patients with a complex clinical diagnosis. Orga-
nizational barriers to recruitment were lack of available
colorectal surgeons on call, lack of research nurse support
and lack of previous experience in recruiting into trials.
Feasibility and acceptability of trial processes
Data compliance
Overall, compliance with collection of clinical and
patient-reported HRQoL data at baseline and follow-up
was good (Table 2). Baseline compliance for clinical and
HRQoL data was 99⋅8 and 93⋅8 per cent respectively.
Data compliance rates related to important clinical end-
points, including conversion rates, reoperation rates,
readmission rates, PSIs, duration of hospital stay, postop-
erative morbidity and mortality rates, and restoration of
gastrointestinal function, were all above 95 per cent. Com-
pliance rates for clinical data remained above 90 per cent
throughout follow-up (Table 2). Compliance rates for the
patient-reported HRQoL questionnaires declined during
the trial follow-up period to 58⋅3 per cent at 12months
(Table 2; Table S1, supporting information). Healthcare
resource use data provided by healthcare professionals
were of high quality and in most instances achieved 100
per cent completion. Patient-completed resource use form
returns declined over time but were at least 50 per cent at
6months (Table S2, supporting information).
Blinding
Eight patients were unblinded during the trial: one by the
anaesthetic team before surgery, two after operation, three
during dressing changes, and two before filling out the
Bang Blinding Index form. The Bang Blinding Index was
0⋅21 (95 per cent c.i. 0⋅14 to 0⋅27) in the laparoscopic and
0⋅53 (0⋅48 to 0⋅59) in the open arm. These results suggest
that there was a failure to adequately blind patients in both
treatment arms.
Acceptability of trial processes
Qualitative interviews conducted with patients identified
the trial processes to be acceptable; however, patients felt
that the number of questionnaires required to be com-
pleted was high. Patients thought the pain questionnaire
(Brief Pain Inventory) was irrelevant and not an appro-
priate assessment measure in the emergency setting. They
would have liked online and paper access to questionnaires.
Patients found the process of blinding unnecessary, and
often guessed their treatment allocation correctly. They
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Table 1 Baseline characteristics
Laparoscopic (n = 33) Open (n = 31) Total (n = 64)
Age (years)
18–49 7 9 16
50–59 4 4 8
60–69 11 6 17
70–79 6 5 11
≥80 5 7 12
BMI (kg/m2)
<25⋅0 14 14 28
25⋅0–29⋅9 12 12 24
≥30⋅0 7 5 12
ASA fitness grade
I 6 10 16
II 22 14 36
III 5 7 12
Preoperative diagnosis
Colorectal cancer 14 9 23
Diverticular disease 7 6 13
Inflammatory bowel disease 4 6 10
Other 8 10 18
Intended surgical procedure
Segmental colectomy 0 1 1
Right hemicolectomy 14 10 24
Left hemicolectomy 0 1 1
Sigmoid colectomy 1 5 6
Hartmann’s procedure 10 9 19
Subtotal colectomy 6 4 10
Other 2 1 3
Table 2 Data compliance at candidate time points during trial
Visit attendance compliance (%)
Clinical data
compliance (%)
Overall patient-reported
HRQoL questionnaire
compliance (%)
Attended,
in hospital
Attended, via
telephone follow-up
Attended, method of
attendance unknown*
Baseline 99⋅8 93⋅8 n.a. n.a. n.a.
3 days after surgery 100 98⋅4 98 n.a. n.a.
7 days after surgery 100 98⋅4 84 9 n.a.
30days after surgery 95⋅0 76⋅7 28 31 22
3months after surgery 94⋅8 70⋅7 28 38 9
6months after surgery 98⋅2 64⋅9 31 33 6
12months after surgery 95⋅5 58⋅3 16 47 5
Overall compliance 98⋅2 82⋅0
Candidate time points are time points that are likely to be included in a definitive phase III trial. *Method of attendance was not collected on earlier versions
of case report forms. HRQoL, health-related quality of life; n.a., not applicable.
expressed a preference to be told of their treatment alloca-
tion immediately after surgery, as opposed to being blinded
for up to 7 days.
Overall, healthcare professionals were accepting of the
trial design and trial-related processes. Despite appropriate
measures being in place to maintain blinding, including
appropriate ward notes, team briefings across all medical
and nursing staff, and appropriate signage and documen-
tation, surgeons felt that blinding was impractical in the
emergency setting. The follow-up processes were deemed
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Table 3 Safety data
Laparoscopic Open Overall
Intraoperative complications (%) 3 (0, 16) 3 (0, 17) 3 (0, 11)
30-day postoperative complications (%) 27 (13, 46) 42 (25, 61) 34 (23, 47)
90-day postoperative complications (%) 36 (20, 55) 42 (25, 61) 39 (27, 52)
Patient safety indicators (%) 12 (3, 28) 16 (6, 34) 14 (7, 25)
30-day postoperative mortality (%) 0 (0, 11) 3 (0, 17) 2 (0, 8)
90-day postoperative mortality (%) 0 (0, 11) 3 (0, 17) 2 (0, 8)
Values in parentheses are 95 per cent confidence intervals.
to be challenging by the research nurses, as the time points
did not always coincide with a natural clinical visit. How-
ever, surgeons regarded the time points as important and
agreed that the proposed time points were appropriate to
ensure that all relevant differences between the two treat-
ment arms were captured appropriately. Surgeons agreed
that a minimum follow-up of 12months was necessary for
appropriate evaluation of the short- andmedium-term out-
comes of emergency laparoscopic colorectal surgery.
Safety
Overall, the safety data obtained for laparoscopic emer-
gency colorectal surgery indicated an acceptable safety
profile. A total of 22 patients experienced a postoperative
complication within 30 days; this extended to 25 patients
within 90 days (Table 3). There were a total of four deaths
during the trial period, one within 90 days of surgery.
There were 13 conversions from laparoscopic to open
surgery, a rate of 39 (95 per cent c.i. 23 to 58) per cent.
The decision to convert was made on establishment of
pneumoperitoneum in one patient, following a period of
trial dissection in 11 and because of an intraoperative
complication in one patient.
Endpoint evaluation
Qualitative interviews with patients identified postopera-
tive complications as an important outcome after emer-
gency surgery. Other important outcomes to patients were
HRQoL and postoperative recovery. Surgeons participat-
ing in the LaCeS feasibility trial shared this perspective,
and considered a reduction in postoperative complications
to be an important key outcome in the evaluation of laparo-
scopic emergency colorectal surgery.
Discussion
LaCeS has demonstrated that it is possible to recruit to
a surgical trial in the emergency setting, with good com-
pliance with trial procedures and processes, and overall
acceptability by patients and clinicians. The safety data sug-
gest that emergency colorectal laparoscopic surgery has
an acceptable profile, with the morbidity rate as expected.
The observed conversion rate is close to current practice;
NELA1 reported a rate of 47 per cent.
The LaCeS trial is relevant to a significant proportion
of patients undergoing emergency surgery; a population of
564 patients who underwent emergency colorectal surgery
across the five participating centres was identified from the
NELA data set during recruitment. The steady-state rates
of recruitment suggest that it is feasible to recruit across
a range of hospital types and emergency surgery services,
including split subspecialty (upper and lower gastrointesti-
nal surgery) and general surgery on-call rotas. The abil-
ity to recruit across a range of hospitals is important to
ensure appropriate upscaling to a definitive phase III trial,
to ensure the generalizability of results, and to facilitate
implementation.
Challenges to recruitment in surgical trials are well rec-
ognized, and include lack of equipoise, the complexity of
combining clinical and research activities, lack of training
and inability to explore patient treatment preferences29–31.
There is a paucity of research into recruitment strategies in
the emergency setting32. The use of qualitative methods to
explore recruitment within elective clinical trials is effective
in identifying challenges, proposing appropriate strategies
and driving training pathways33,34. Qualitative initiatives
such as QuinteT (qualitative research integrated in trials)35
and Granule (generating recruiters for randomized trials
in surgery) have improved how surgeons are trained to
approach, recruit and randomize patients.
The routine collection of patient-reported outcome data
in the emergency setting was previously documented to
be of low quality, with poor reporting of baseline data36.
This is coupled with high rates of attrition, with Mason
and colleagues37 reporting 6-week response rates of 48⋅4
per cent, despite an initial baseline compliance rate of 93
per cent among 156 patients presenting to emergency gen-
eral surgery services. LaCeS has demonstrated that it is
possible to collect high-volume, good-quality clinical and
© 2020 The Authors. British Journal of Surgery published by John Wiley & Sons Ltd www.bjs.co.uk BJS
on behalf of BJS Society Ltd.
D. P. Harji, H. Marshall, K. Gordon, M. Twiddy, A. Pullan, D. Meads et al.
patient-reported outcome data in the emergency setting
both at baseline and during follow-up. Although attrition
was noted during follow-up with regard to HRQoL data,
response rates in this study were much higher than pre-
viously reported at all candidate follow-up time points37;
the lowest response rate of 58⋅3 per cent was observed at
12months. Data from qualitative patient interviews sug-
gested that the burden of questionnaire completion was
high and some questionnaires were deemed irrelevant to
the patients’ clinical status. It is possible that as patients
improved clinically and recovered from surgery, they were
less inclined to complete HRQoL questionnaires owing to
the lack of relevance. The mode of follow-up visits also
changed as the trial progressed, with a greater propor-
tion of the later visits being done by telephone. Research
nurses stated this made it more difficult to complete and
collect HRQoL data, which may have contributed to the
reduced response rates at 6 and 12months after surgery.
The collection of HRQoL data in the emergency setting
therefore requires the use of appropriate, accessible and
user-friendly patient-reported outcome measures, coupled
with a follow-up strategy that is relevant and acceptable to
patients and clinicians.
Feasibility trials are important in providing sufficient
methodological evidence regarding trial design, delivery
and justification. The successful delivery of the LaCeS
feasibility trial has shown that it is possible to recruit in the
emergency setting and to initiate trial-related processes
while delivering definitive emergency care in a timely
manner. This trial has enabled the authors to pilot data col-
lection, blinding and follow-up processes, and assess their
efficacy appropriately. Employing this approach before
conducting a large-scale definitive trial ensures the feasibil-
ity of delivery of that trial, the acceptability and appropriate
modification of the proposed trial processes. To evaluate
the role, efficacy and safety of laparoscopic surgery in
the emergency colorectal setting, a further large-scale,
definitive phase III multicentre RCT is required. Data
from the LaCeS feasibility trial have demonstrated that it
is feasible to deliver such a trial of laparoscopic versus open
emergency colorectal resection within the NHS.
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